Healthcare AI News 3/4/26

News

Oura is testing a women’s health AI model for its smart ring that allows users to ask questions about reproductive health. The feature is an enhancement to Oura Advisor, which analyzes health trends, visualizes collected data, and creates health plans.

Quest Diagnostics adds an AI-powered chat feature to its patient app and portal that answers questions about lab results.

Business

UnityAI, which offers a healthcare agentic AI platform, raises $8.5 million in Series A funding.

OpenEvidence launches Doctor Dialer, which lets clinicians place calls using a customizable caller ID number, send and receive secure messages within the OpenEvidence app, send and receive faxes, leave straight-to-voicemail messages for patients, and automatically create clinical notes.

GenieMD announces a health chatbot that offers free healthcare guidance and connects users to a board-certified doctor for a paid telehealth visit if needed.

Other

A California doctor warns patients that emails linking to a video offering $45 telehealth visits with him via WhatsApp are a scam. The video is an AI-generated fake that uses images of him and a colleague, and recipients, many of them older patients, are asked to provide payment information to schedule an appointment.

A retired pediatrician testifies in Rhode Island Family Court that he asked ChatGPT if physicians can prescribe medications for themselves or family members as he faces scrutiny in a contentious trial over grandparents’ visitation rights. His  son-in-law alleges that the grandfather’s medical advice and prescribing practices contributed to his wife’s death and harmed their child. He also filed a complaint with the state department of health that accused his in-laws of engaging in Munchausen Syndrome by Proxy by prescribing excessive amounts of drugs to his wife and daughter to make them dependent on them.

Contacts

Mr. H, Lorre, Jenn, Dr. Jayne.
Get HIStalk updates.
Send news or rumors.
Follow on X, Bluesky, and LinkedIn.
Sponsorship information.
Contact us.